(Q55034563)

16 June 2018

http://europepmc.org/abstract/MED/11191542

title

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. (English)

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

0 references

0 references

1 reference

1 reference

9

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

Ratko Djukanovic

10

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

Stephen Holgate

12

object named as

S T Holgate

1 reference

16 June 2018

11

T T Hansel

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

author name string

M J Leckie

1

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

A ten Brinke

2

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

J Khan

3

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

Z Diamant

4

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

B J O'Connor

5

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

C M Walls

6

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

A K Mathur

7

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

H C Cowley

8

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

P J Sterk

13

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

P J Barnes

14

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

language of work or name

English

0 references

publication date

1 December 2000

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

published in

The Lancet

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

volume

356

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

issue

9248

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

page(s)

2144-2148

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

cites work

Eosinophilic Inflammation in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

1 reference

7 January 2021

Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Airway wall remodelling in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Relationship between IL-4 and IL-5 mRNA Expression and Disease Severity in Atopic Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

The late asthmatic response is associated with baseline allergen-specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin-5

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Comparison of incremental and bolus dose inhaled allergen challenge in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Reproducibility of allergen-induced early and late asthmatic responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Effect of cyclosporin A on the allergen-induced late asthmatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

The relationship between inflammation and hyperreactivity of the airways in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Allergic networks regulating eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Dissociation between Airway Inflammation and Airway Hyperresponsiveness in Allergic Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903496-6

7 January 2021

10.1016/S0140-6736(00)03496-6

Identifiers

DOI

1 reference

16 June 2018

http://europepmc.org/abstract/MED/11191542

1 reference

16 June 2018